A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

Blacktown Cancer and Haematology Centre, Blacktown

Calvary Mater Newcastle, Waratah

Riverina Cancer Care Centre, Wagga Wagga

Orange Health Service (Central West Cancer Care Centre), Orange

The Alfred Hospital, Melbourne

Austin Health, Heidelberg

Monash Health, Clayton

Icon Cancer Centre South Brisbane, South Brisbane

Pindara Private Hospital, Benowa

Flinders Centre For Innovation in Cancer (Fcic), Bedford Park

Lyell McEwin Hospital, Elizabeth Vale

One Clinical Research, Nedlands

St John of God, Murdoch, Murdoch

Laura and Isaac Perlmutter Cancer Center At Nyu Langone Health, New York

Columbia University Medical Center, New York

Perlmutter Cancer Center At Winthrop Oncology Hematology Associatesnyu Winthrop Hospital, Mineola

Virginia Cancer Specialists, Fairfax

Duke Cancer Center, Durham

Baptist Md Anderson Cancer Center, Jacksonville

University of Tennessee Medical Center, Knoxville

Norton Cancer Institute, Louisville

Baptist Health Lexington, Lexington

University of Kentucky Markey Cancer Center, Lexington

Fort Wayne Medical Oncology and Hematology, Fort Wayne

St Vincent Frontier Cancer Center, Billings

Washington University School of Medicine, St Louis

Ochsner Clinic Foundation, New Orleans

Pontchartrain Cancer Center, Covington

Ut Southwestern Medical Center, Dallas

Ut Health San Antonio Mays Cancer Center, San Antonio

Banner Md Anderson Cancer Center, Gilbert

University of New Mexico Cancer Center, Albuquerque

Comprehensive Cancer Centers of Nevada, Las Vegas

Cancer Care Specialists, Reno

Usc Norris Comprehensive Cancer Center (Nccc), Los Angeles

Valkyrie Clinical Trials, Los Angeles

UCLA, Los Angeles

Toi Clinical Research, Cerritos

Hoag Memorial Presbyterian, Newport

Kaiser Permanente Northern California, Vallejo

Multicare Health System Institute For Research and Innovation, Tacoma

Cancer Care Northwest, Spokane Valley

Alaska Oncology and Hematology, Llc, Anchorage

Peking University First Hospital, Beijing

Beijing Tsinghua Changgung Hospital, Beijing

The First Hospital of Jilin University, Changchun

Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai

Shanghai 10Th Peoples Hospital, Shanghai

Shanghai East Hospital Branch Hospital, Shanghai

The First Peoples Hospital of Changzhou, Changzhou

Affiliated Hospital of Jiangnan University South Campus, Wuxi

Nantong First Peoples Hospital, Nantong

The Second Hospital of Anhui Medical University, Hefei

Shandong Cancer Hospital, Jinan

Qingdao Municipal Hospital, Qingdao

Jining No.1 Peoples Hospital West Branch, Jining

Linyi Peoples Hospital, Linyi

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Tianjin Union Medical Center (Nankai University Affiliated Hospital), Tianjin

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

Fujian Medical University Union Hospital, Fuzhou

The First Affiliated Hospital of Xiamen University, Xiamen

Quanzhou First Affliated Hospital of Fujian Medical University, Quanzhou

Hunan Cancer Hospital, Changsha

Hubei Cancer Hospital, Wuhan

Henan Cancer Hospital, Zhengzhou

Nanyang Central Hospital, Nanyang

Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North), Guangzhou

Zhujiang Hospital of Southern Medical University, Guangzhou

The First Affiliated Hospital of Shantou University Medical College, Shantou

Gansu Provincial Hospital, Lanzhou

General Hospital of Ningxia Medical University, Yinchuan

The Xinjiang Uygur Autonomous Region Peoples Hospital, Ürümqi

Karamay Central Hospital of Xinjiang, Karamay

Shanxi Provincial Cancer Hospital, Taiyuan

Pan American Oncology Trials, Llc, Rio Piedras